Conclusion The VHL gene may frequently mutate in Chinese patients with primary sporadic renal clear cell carcinoma.
结论国人原发性散发性肾透明细胞癌中存在VHL基因的突变。
Objective To evaluate the efficacy and safety of sunitinib in the treatment of metastatic renal clear cell carcinoma in our single center.
目的评价单中心舒尼替尼治疗转移性肾脏透明细胞癌的疗效和安全性。
Objective To study the expression of cyclooxygenase-2 (COX-2) in renal clear cell carcinoma tissues and its relation with the clinical tumor stage.
目的研究环氧化酶-2（COX-2）在人肾透明细胞癌组织中的表达，分析其表达水平与肿瘤分期的关系。
Objective to investigate the pathological features of renal clear cell carcinoma (RCCC) in children and its relationship to the DNA content of cancer cells and DNA ploidy.
目的探讨儿童肾透明细胞癌病理形态特点及癌细胞DNA含量和倍体的关系。
To explore distribution of chemokine receptor CXCR4 on clear cell renal carcinoma.
目的研究肾透明细胞癌中趋化性细胞因子受体CX CR4的分布。
Further clinical follow-up is needed to determine whether these tumors are more indolent compared with the conventional clear cell renal cell carcinoma.
需要进一步临床随访，来确定与传统透明细胞肾细胞癌相比这些肿瘤是否更为惰性。
Multilocular renal cell carcinoma has aggregates of clear cells within the septa dividing cystic Spaces.
多房性肾细胞癌的囊内有透明细胞的聚集，其间有分隔。
Conclusions: The expression levels of NOTCH1 and JAG1 were higher in clear cell renal cell carcinoma than in normal kidney tissues and correlated with patients' clinical and pathological variables.
结论：肾透明细胞癌NOTCH1和JAG1表达均高于正常肾组织，且与肿瘤分级、分期及肿瘤大小有关。
Conclusions: The expression levels of NOTCH1 and JAG1 were higher in clear cell renal cell carcinoma than in normal kidney tissues and correlated with patients' clinical and pathological variables.
结论：肾透明细胞癌NOTCH1和JAG1表达均高于正常肾组织，且与肿瘤分级、分期及肿瘤大小有关。
应用推荐